A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Recently, a prognostic index including six risk factors (RFs) (unfavourable Eastern Cooperative Oncology Group performance status [ECOG PS], presence of liver metastases, short response to luteinizing hormone-releasing hormone [LHRH] agonists/antagonists, low albumin, increased alkaline phosphatase...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Canadian Urological Association journal 2018-02, Vol.12 (2), p.E47-52
Hauptverfasser:	Khalaf, Daniel Joseph, Avilés, Claudia M, Azad, Arun A, Sunderland, Katherine, Todenhöfer, Tilman, Eigl, Berhard J, Finch, Daygen, Le, Lyly, Atwell, Andrew, Keith, Bruce, Kollmannsberger, Christian, Chi, Kim N
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer patients Care and treatment Original Research Patient outcomes Prostate cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!